4-Aminoquinazolin compounds as prolyl hydroxylase inhibitors

US10246442B2 · kind B2 · utility

Assignee

• Janssen Pharmaceuticals, Inc. · BE

Inventors

• Michael H. Rabinowitz · San Diego, US
• Mark D. Rosen · San Diego, US
• Kyle T. Tarantino · Princeton, US
• Hariharan Venkatesan · San Diego, US

Key dates

• Filing date: Feb 17, 2017
• Grant date: Apr 2, 2019
• Expiry date: Feb 17, 2037

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D417/14
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Aminoquinazolinyl compounds of formula (I) are described, which are useful as prolyl hydroxylase inhibitors. Such compounds may be used in pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by prolyl hydroxylase activity. Thus, the compounds may be administered to treat, e.g., anemia, vascular disorders, metabolic disorders, and wound healing.